24 July 2023
Recordings from Drug Discovery & Development Symposium 2023 - Lessons learnt from clinical trials in PH groups 2 and 3
Lessons learnt from clinical trials in PH groups 2 & 3: What are the similarities & differences in pathogenesis & pathophysiology?
Chairs: Paul Corris & Steven Nathan
Panellists: Jordan Pomeroy & Sylvia Nikkho
Pulmonary Hypertension Group 2: Pathophysiology & pathogenesis; In adults
Speaker: Raymond Benza
Pulmonary Hypertension Group 2: In paediatrics
Speaker: Rachel Hopper
Panel discussion & debate
Pulmonary hypertension group 3: Pathophysiology & pathogenesis
Speaker: Paul Hassoun
Pulmonary hypertension group 3: In adults
Speaker: Steven Nathan
Pulmonary hypertension group 3: In paediatrics
Speaker: Steven Abman
Pulmonary hypertension group 3: Panel discussion and debate
Videos are uploaded across 5 pages:
- Page 1: Digital Health TEchnology (DHT) advancements & implementation at the FDA, Foundation for National Institutes of Health (FNIH) & Pharma to optimise clinical trial designs & endpoints in PH; and FNIH, Pharma & academia pioneering of digital endpoints
- Page 2: Novel trial designs: The decentralised trial design: overcoming the hidden obstacles
- Page 3: Lessons learnt from clinical trials in PH groups 3 & 3: What are the similarities & differences in pathogenesis & pathophysiology?
- Page 4: Novel drug & device therapies
- Page 5: Disruptive technologies in novel drug discovery
